Comparison of methods to identify individuals at increased risk of cardiovascular disease in Italian cohorts

Our study confirms that the use of different risk-assessment methods in clinical practice can substantially change risk estimation and consequently statin prescription rate. The Framingham-based risk-assessment methods and particularly the NCEP-ATPIII guidelines select for lipid-lowering treatment a higher number of subjects than those identified according to European and Italian recommendations.